14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PASG
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Passage Bio, Inc. stock price after Friday trading.
(Updated on May 03, 2024)

Hold candidate since May 03, 2024 PDF

The Passage Bio, Inc. stock price fell by -2.24% on the last day (Friday, 3rd May 2024) from $1.34 to $1.31. During the last trading day the stock fluctuated 6.15% from a day low at $1.30 to a day high of $1.38. The price has fallen in 6 of the last 10 days but is still up by 13.91% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -31 thousand shares and in total, 41 thousand shares were bought and sold for approximately $53.72 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.72% during the next 3 months and, with a 90% probability hold a price between $1.06 and $1.81 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PASG Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Passage Bio, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.32. On a fall, the stock will find some support from the short-term average at $1.30. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, February 28, 2024, and so far it has fallen -24.28%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Passage Bio, Inc. stock

Passage Bio, Inc. finds support from accumulated volume at $1.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0800 between high and low, or 6.15%. For the last week the stock has had daily average volatility of 8.58%.

Our recommended stop-loss: $1.23 (-5.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 46 days ago.)

Trading Expectations (PASG) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Passage Bio, Inc. to open at $1.33, and during the day (based on 14 day Average True Range), to move between $1.20 and $1.42, which gives a possible trading interval of +/-$0.110 (+/-8.42%) up or down from last closing price. If Passage Bio, Inc. takes out the full calculated possible swing range there will be an estimated 16.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.32 (0.76%) than the support at $1.30 (0.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Passage Bio, Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.370. We will update the financials statements for Passage Bio, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.32% in the first trading day after earnings release.

Is Passage Bio, Inc. stock A Buy?

Passage Bio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.023 Hold/Accumulate Upgraded

Predicted Opening Price for Passage Bio, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$1.33 ( 1.53%) $1.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PASG

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.41 7.63 %
R2 1.38 5.30 %
R1 1.36 3.86 %
Current price: 1.31
Support S1 1.30 -0.81 %
S2 1.28 -2.25 %
S3 1.25 -4.58 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.40 6.87 %
R2 1.35 3.05 %
R1 1.32 0.763 %
Current price 1.31
Support S1 1.30 -0.763%
S2 1.27 -3.05%
S3 0.99 -24.43%

FAQ

What is the symbol for Passage Bio, Inc. Stock and on which exchange is it traded?
The symbol for Passage Bio, Inc. is PASG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Passage Bio, Inc. Stock?
Passage Bio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Passage Bio, Inc. Stock?
Passage Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Passage Bio, Inc. Stock.

What's the current price of Passage Bio, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Passage Bio, Inc. (PASG) share was $1.31.

What is the 52-week high and low for Passage Bio, Inc. Stock?
The 52-week high for Passage Bio, Inc. Stock is $1.79 and the 52-week low is $0.575.

What is the market capitalization of Passage Bio, Inc. Stock?
As of the May 03, 2024, the market capitalization of Passage Bio, Inc. is 80.711M.

When is the next earnings date for Passage Bio, Inc.?
The upcoming earnings date for Passage Bio, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Passage Bio, Inc.

Passage Bio. Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the... PASG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT